RCE 3.36% 57.5¢ recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-2

  1. 5,278 Posts.
    lightbulb Created with Sketch. 683
    Only read top lines but Yess yes yes lol. Great looking and have been desperately looking forward to

    Highlights:• Broad spectrum antibiotic activity on bacterial Burn Wound infections withvisible infection reduction <24 hours on all patients to date• All infections cleared within 5 days (acute) or 7 days (chronic); clinicians reducing treatment windows per protocol/positive patient indications• Burn wound infections consisted of Gram-positive and Gram-negative bacteria, including multi-drug resistant and ‘biofilm’ categorised forms• Update in-line with reaching clinical trial end-points; patient recruitment ongoing
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
57.5¢
Change
-0.020(3.36%)
Mkt cap ! $117.2M
Open High Low Value Volume
57.5¢ 58.0¢ 57.5¢ $13.44K 23.37K

Buyers (Bids)

No. Vol. Price($)
1 143 57.5¢
 

Sellers (Offers)

Price($) Vol. No.
58.0¢ 4749 2
View Market Depth
Last trade - 15.57pm 21/06/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.